Skip to main content
Loading Events

« All Events

  • This event has passed.

Pharma Possibilities of Therapeutic Monoclonal Antibodies

May 12, 2021

Over the course of the last decade, we have witnessed the emergence of therapeutic antibodies, and more specifically, monoclonal antibodies (mAbs) as one of the fastest-growing classes of pharmaceutical drugs.

It (along with recombinant proteins) has powered the growth of the biopharmaceuticals industry, and it is expected to grow to a market value of USD 496.71 billion by 2026, with a CAGR of 7.32% over the forecast period 2021-2026. Notably, the global therapeutic monoclonal antibody market is expected to be valued at $300 billion by 2025.

Some significant trends that appear to be developing across the industry landscape include greater development of bispecific antibodies, antibody-drug conjugates, and companion diagnostics, which should help to identify the most appropriate patient populations for treatment. Additionally, new markets are expected to open up in growing economies. How companies respond to these scientific and business challenges will define their future as producers of innovative mAbs and Fc fusion proteins of the future.

Thus, interest in therapeutic monoclonal antibodies has piqued industry onlookers. This can perhaps be attributed to the incredible specificity made possible by mAbs, epitomising precision medicine via an incredibly flexible platform boasting numerous advantages. The greatest challenge before us now is to understand the underlying biology in order to ensure the efficacy of medical treatments, and usher in an entirely new generation of therapeutic agents built on the premise of molecular-targeting medicine.

Through the lens of a new knowledge platform, christened Futurescope, Bluetech Media aims to explore the Pharma Possibilities of Therapeutic Monoclonal Antibodies. By shining a spotlight on this game-changing development, we seek to better understand its use cases, implications, and future horizons.

Visit Website


May 12, 2021
Event Category: